Omeros | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Adma Biologics USD 349.02M 117.13M 2024-12
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Cytokinetics USD -266413000 131.04M 2025-03
Dynavax Technologies USD 530.94M 65.86M 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
Insmed USD 99.16M 186.22M 2025-03
Knight Therapeutics CAD 773.91M 11.11M 2024-09
MacroGenics USD 116.06M 4.01M 2024-12
Pacira USD 798.54M 20.19M 2025-03
Pfizer USD 90.34B 2.14B 2025-03
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
United Therapeutics USD 6.81B 363.2M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Omeros Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.